Prostate-specific membrane antigen (PSMA), a type II transmembrane glycoprotein, is expressed in all forms of prostate tissue, but is upregulated 10-fold in prostate cancer (Ma et al., 2004). The gene discussed is FOLH1; the disease is prostate carcinoma.